Dupilumab-Treated Patients with Moderate-To-Severe Asthma Are More Likely to Meet Clinical Remission Criteria: Results from the Vestige Trial
AuthID
P-017-Q1D
P-017-Q1D
© 2025 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service